data_1ba4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ba4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.178 0 CA-C-O 121.412 0.625 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -23.69 67.4 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -60.6 -43.06 97.86 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -43.68 80.78 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -52.5 -52.09 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -57.99 -46.59 84.96 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -51.92 54.34 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.41 -46.77 66.48 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.58 -49.55 76.02 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.205 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -49.6 -53.3 24.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.552 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.12 -53.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.085 -1.871 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.89 -54.52 17.9 Favored Glycine 0 N--CA 1.496 2.68 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.546 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -64.47 -51.45 63.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -41.92 -45.46 3.75 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.053 -0.976 . . . . 0.0 113.138 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -36.6 -39.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.463 1.102 . . . . 0.0 112.798 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.37 -58.1 15.0 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.93 83.54 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.104 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -53.64 -54.28 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.153 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.2 mt -54.87 -47.6 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.99 -49.63 54.56 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.0 -48.58 79.6 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.642 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.4 mtp -52.0 -49.67 62.87 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.155 0.909 . . . . 0.0 109.516 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.0 -53.19 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.719 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.11 137.91 4.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.41 97.92 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.83 33.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.109 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -14.22 3.08 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.26 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -74.89 -57.14 4.09 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -37.43 78.51 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.486 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.42 -53.26 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.31 -49.46 69.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -54.96 37.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.98 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.62 -45.6 63.31 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.478 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -56.91 -52.26 65.86 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -50.76 -52.27 42.32 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.085 1.421 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.64 -50.8 56.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.35 -56.49 23.16 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.154 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -53.41 -47.71 69.35 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.65 -59.59 4.4 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.618 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -50.97 -44.59 60.66 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.065 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.38 -55.0 30.67 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.73 80.52 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -51.31 -54.29 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.351 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.91 -48.45 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.96 58.29 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.79 -47.89 81.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -52.34 -54.49 31.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.771 0.67 . . . . 0.0 109.227 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.85 -53.65 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 125.182 1.551 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.53 61.99 0.29 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -159.17 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.67 29.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.098 0.951 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 38' ' ' GLY . 55.3 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 116.441 -1.742 . . . . 0.0 109.76 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 122.106 0.955 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -48.06 -32.4 6.69 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.435 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -53.18 54.55 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.456 0.646 . . . . 0.0 110.601 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -36.44 79.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.207 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -53.68 -49.7 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -55.97 -49.51 73.36 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.27 -55.51 20.85 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.822 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.04 -46.51 68.49 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.646 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.61 -49.54 74.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -52.91 -53.41 49.67 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.203 1.001 . . . . 0.0 109.207 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.4 t -49.59 -51.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.15 -54.39 35.94 Favored Glycine 0 N--CA 1.498 2.811 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -50.36 -51.79 42.81 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.708 0.766 . . . . 0.0 110.617 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.13 -62.49 1.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.458 -1.247 . . . . 0.0 113.432 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -55.36 -37.61 67.73 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.168 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.27 -56.67 23.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.84 77.41 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.735 0.778 . . . . 0.0 110.821 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.2 mt -53.64 -56.89 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.311 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.9 mt -55.88 -41.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.75 -53.49 39.01 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -38.23 86.65 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtp -60.35 -52.89 63.31 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.49 -47.19 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.592 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.42 3.59 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.287 0.992 . . . . 0.0 113.112 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . 83.88 32.32 24.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.23 23.57 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.773 0.796 . . . . 0.0 109.982 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 38' ' ' GLY . 41.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 116.609 -1.662 . . . . 0.0 109.829 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.3 m170 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.94 0.876 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.08 -35.66 67.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -52.47 -50.02 63.51 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.268 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -41.72 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.11 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.6 -51.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.91 -48.55 79.57 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.989 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -51.77 46.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.31 61.25 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.089 0.471 . . . . 0.0 110.604 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.94 -47.96 76.6 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -52.88 -51.83 59.7 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.338 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -50.56 -48.99 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.588 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.18 -55.53 27.81 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -52.24 -47.75 65.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.976 0.893 . . . . 0.0 110.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -51.2 -57.55 8.49 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.575 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.28 -46.71 18.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 123.469 0.481 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.56 -56.04 26.67 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.8 78.87 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.304 0.573 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.5 -53.11 17.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.3 mt -53.58 -48.17 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.72 -51.33 53.42 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.77 -45.18 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.783 -0.208 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.0 mtp -55.22 -53.25 58.41 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -49.4 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 124.77 1.294 . . . . 0.0 109.691 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.16 -57.25 13.63 Favored Glycine 0 N--CA 1.494 2.528 0 O-C-N 124.168 0.918 . . . . 0.0 112.8 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.14 -9.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.22 33.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.599 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.887 0.851 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -32.04 63.2 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.524 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -53.57 54.46 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.722 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -38.39 86.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.56 -53.09 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -54.36 -49.48 69.72 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -54.05 29.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.41 67.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.68 -48.35 77.82 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.028 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -52.25 -51.36 58.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.134 0.896 . . . . 0.0 110.008 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.0 t -52.81 -50.45 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.518 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.08 -54.8 33.67 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.494 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.4 t -76.08 -5.46 46.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.13 -53.09 62.14 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.109 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -50.58 -40.44 52.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.52 -58.58 13.83 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.13 75.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.502 0.667 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.3 mt -53.1 -55.76 10.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.896 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -55.31 -46.64 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.194 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.14 -49.17 60.54 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.92 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -66.05 -33.83 76.7 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 117.703 -1.599 . . . . 0.0 108.799 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.58 -59.19 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.649 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.54 -76.19 1.12 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.34 -68.53 0.07 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.35 57.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 99.8 t . . . . . 0 N--CA 1.496 1.849 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.707 0.765 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.65 -44.27 66.03 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.193 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -53.48 -55.78 22.48 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.6 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.66 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.05 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.44 -52.67 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -57.46 -48.81 78.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.485 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.29 -55.19 23.02 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.046 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.16 -47.29 65.53 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.374 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -55.27 -50.32 69.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.31 -52.34 59.43 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.406 1.098 . . . . 0.0 109.329 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.69 -49.3 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.238 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.81 -45.63 5.85 Favored Glycine 0 N--CA 1.501 2.971 0 O-C-N 124.963 1.414 . . . . 0.0 112.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -82.37 -50.64 8.68 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.885 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -50.42 -48.79 56.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -50.1 -35.91 27.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.53 -57.23 20.88 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.6 -44.15 96.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -53.78 -49.67 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.46 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.69 -45.96 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -53.75 37.27 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.715 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.39 -36.82 85.15 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.072 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.5 tpt -60.84 -45.95 92.46 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.65 -54.42 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.13 -1.395 . . . . 0.0 108.535 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.58 -18.96 0.02 OUTLIER Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.915 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.94 -2.31 13.53 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.683 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.4 31.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.771 0.796 . . . . 0.0 108.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 116.371 -1.776 . . . . 0.0 109.952 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -47.11 -45.85 22.46 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.444 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -60.71 2.88 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.069 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -36.19 83.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.407 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -53.42 -56.07 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -50.8 -49.8 57.63 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.955 0.883 . . . . 0.0 109.225 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -52.33 60.96 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.58 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.49 -45.67 62.9 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.92 -50.78 67.96 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.01 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -51.83 -51.93 52.99 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.042 1.401 . . . . 0.0 109.4 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.92 -48.78 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.348 -2.206 . . . . 0.0 110.625 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.51 -50.64 18.12 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -46.57 -55.82 7.0 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.203 1.001 . . . . 0.0 109.883 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -62.48 -48.93 77.44 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.513 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -44.59 -47.29 10.33 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.915 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.54 -55.21 14.06 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.51 83.24 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.091 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mt -49.13 -49.9 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.998 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.84 -51.86 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.23 35.95 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.42 -53.68 26.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.2 ptm -60.59 -35.8 76.99 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.782 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.42 -50.47 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.71 40.71 2.12 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.27 -32.67 0.48 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t 41.83 36.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.499 1.142 . . . . 0.0 111.475 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.338 -1.792 . . . . 0.0 109.793 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.669 0.747 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.38 -45.86 62.61 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.067 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -50.58 -57.3 8.49 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.303 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -38.3 90.52 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.314 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -52.88 -52.22 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.65 -50.88 69.03 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.817 0.818 . . . . 0.0 109.48 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -55.19 26.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.941 -1.482 . . . . 0.0 109.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.39 64.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.201 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -53.02 62.93 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -47.53 -53.28 14.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.191 0.996 . . . . 0.0 109.595 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.19 -53.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.86 -49.16 9.16 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -70.25 -65.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.983 -1.108 . . . . 0.0 110.812 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -61.6 -73.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.33 -36.07 13.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.75 -59.37 10.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.48 87.57 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.143 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.54 -56.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.25 -45.6 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -51.55 47.73 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.715 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -39.29 92.83 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 118.459 -1.296 . . . . 0.0 111.135 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.98 80.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.866 0.729 . . . . 0.0 109.406 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.96 -55.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.549 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.15 49.68 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.84 -1.172 . . . . 0.0 111.973 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.69 -35.93 83.68 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.89 48.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.593 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.761 0.315 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -57.49 -43.62 84.29 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.81 0.814 . . . . 0.0 109.051 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 tptm -57.32 -53.19 60.92 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.421 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -39.53 94.43 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.346 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.21 -55.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -60.77 -47.12 87.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.562 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -54.01 38.16 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.091 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.44 -44.48 65.5 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.289 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.51 -52.66 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.28 -52.37 53.2 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.568 1.175 . . . . 0.0 109.646 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.4 -48.83 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 112.735 -2.029 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.57 -51.28 7.99 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 t -67.15 -58.71 4.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.839 -1.18 . . . . 0.0 110.66 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.3 -71.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.498 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.15 -34.8 23.52 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.18 -60.12 9.49 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.15 -44.12 87.7 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.7 mt -53.25 -55.9 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.89 -46.53 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.64 -50.38 49.21 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.38 -48.64 80.85 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.832 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.2 tpt -52.87 -49.47 65.76 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.98 0.8 . . . . 0.0 110.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.13 -53.07 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.65 -113.92 1.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 -29.42 5.8 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.44 36.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.594 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -59.72 -12.59 7.39 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 0.0 111.237 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -69.06 -51.12 42.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -59.46 -34.92 73.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.885 -1.962 . . . . 0.0 107.489 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.14 -57.2 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -48.7 -49.66 36.9 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.741 0.781 . . . . 0.0 109.784 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.53 -53.44 54.44 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.174 -1.376 . . . . 0.0 108.594 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.05 61.88 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.557 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.0 -51.76 68.34 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.2 -54.0 14.97 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.62 1.2 . . . . 0.0 109.428 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.95 -53.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.684 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.87 -51.25 18.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -62.59 -60.53 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.575 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -58.53 -70.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.044 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -35.82 30.29 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.49 -59.21 11.27 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.0 mt -51.73 -55.64 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.709 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.75 -47.42 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -50.2 47.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 mt -58.88 -48.97 79.52 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.669 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 mtt -53.97 -50.04 67.42 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.913 0.758 . . . . 0.0 110.307 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.24 -50.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.344 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.43 -55.21 27.99 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.88 -33.67 3.93 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.94 27.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.193 -1.861 . . . . 0.0 107.735 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.19 103.51 13.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.28 -19.88 64.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 123.954 0.784 . . . . 0.0 108.941 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.6 t80 176.64 103.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 41.61 61.28 1.9 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 121.117 0.484 . . . . 0.0 112.088 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 p80 38.85 35.19 0.11 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.07 154.98 14.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 p -73.06 157.38 37.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.957 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.64 84.55 0.05 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -54.14 -25.17 20.87 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.481 0.753 . . . . 0.0 110.609 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 69.64 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.224 1.578 . . . . 0.0 111.38 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.9 -166.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.117 0.484 . . . . 0.0 110.801 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -74.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 -4.22 2.92 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 123.798 0.686 . . . . 0.0 112.091 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -23.69 67.4 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -60.6 -43.06 97.86 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -43.68 80.78 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -52.5 -52.09 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -57.99 -46.59 84.96 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -51.92 54.34 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.41 -46.77 66.48 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.58 -49.55 76.02 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.205 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -49.6 -53.3 24.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.552 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.12 -53.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.085 -1.871 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.89 -54.52 17.9 Favored Glycine 0 N--CA 1.496 2.68 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.546 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -64.47 -51.45 63.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -41.92 -45.46 3.75 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.053 -0.976 . . . . 0.0 113.138 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -36.6 -39.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.463 1.102 . . . . 0.0 112.798 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.37 -58.1 15.0 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.93 83.54 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.104 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -53.64 -54.28 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.153 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.2 mt -54.87 -47.6 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.99 -49.63 54.56 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.0 -48.58 79.6 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.642 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.4 mtp -52.0 -49.67 62.87 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.155 0.909 . . . . 0.0 109.516 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.0 -53.19 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.719 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.11 137.91 4.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.41 97.92 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.83 33.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.109 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.21 60.54 2.33 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 53.33 37.47 25.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.049 -1.887 . . . . 0.0 112.393 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -112.94 26.04 10.86 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.268 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 46.36 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 p80 38.25 29.04 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.698 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.64 117.3 1.12 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.589 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.433 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 21.7 m -158.56 166.91 30.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.912 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 69.19 0.02 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.06 170.97 19.44 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -86.07 119.96 26.93 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -112.14 172.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 18.5 m-70 -83.67 28.3 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -151.09 109.28 3.74 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -14.22 3.08 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.26 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -74.89 -57.14 4.09 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -37.43 78.51 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.486 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.42 -53.26 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.31 -49.46 69.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -54.96 37.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.98 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.62 -45.6 63.31 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.478 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -56.91 -52.26 65.86 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -50.76 -52.27 42.32 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.085 1.421 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.433 ' CG1' ' H ' ' A' ' 8' ' ' SER . 48.0 t -54.64 -50.8 56.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.982 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.35 -56.49 23.16 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.154 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -53.41 -47.71 69.35 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.65 -59.59 4.4 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.618 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -50.97 -44.59 60.66 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.065 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.38 -55.0 30.67 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.73 80.52 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -51.31 -54.29 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.351 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.91 -48.45 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.96 58.29 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.79 -47.89 81.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -52.34 -54.49 31.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.771 0.67 . . . . 0.0 109.227 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.85 -53.65 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 125.182 1.551 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.53 61.99 0.29 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -159.17 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.67 29.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.098 0.951 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 38' ' ' GLY . 55.3 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 116.441 -1.742 . . . . 0.0 109.76 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.03 147.52 11.34 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.81 -40.41 95.14 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.9 t80 60.67 99.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.897 1.373 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -135.16 26.74 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.594 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -87.92 42.81 1.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.668 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.54 80.38 2.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.146 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -143.52 131.39 21.53 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.434 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.64 -57.21 0.48 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.03 156.4 37.54 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -135.14 128.36 31.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.31 162.25 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 122.594 1.188 . . . . 0.0 113.577 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -115.53 65.6 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.006 -2.361 . . . . 0.0 106.731 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 53.67 31.52 12.88 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.222 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -48.06 -32.4 6.69 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.435 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -53.18 54.55 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.456 0.646 . . . . 0.0 110.601 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -36.44 79.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.207 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -53.68 -49.7 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -55.97 -49.51 73.36 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.27 -55.51 20.85 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.822 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.04 -46.51 68.49 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.646 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.61 -49.54 74.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -52.91 -53.41 49.67 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.203 1.001 . . . . 0.0 109.207 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.4 t -49.59 -51.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.669 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.15 -54.39 35.94 Favored Glycine 0 N--CA 1.498 2.811 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -50.36 -51.79 42.81 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.708 0.766 . . . . 0.0 110.617 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.13 -62.49 1.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.458 -1.247 . . . . 0.0 113.432 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -55.36 -37.61 67.73 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.168 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.27 -56.67 23.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.84 77.41 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.735 0.778 . . . . 0.0 110.821 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.2 mt -53.64 -56.89 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.311 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.9 mt -55.88 -41.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.75 -53.49 39.01 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -38.23 86.65 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtp -60.35 -52.89 63.31 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.49 -47.19 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.592 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.42 3.59 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.287 0.992 . . . . 0.0 113.112 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . 83.88 32.32 24.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.23 23.57 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.773 0.796 . . . . 0.0 109.982 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 38' ' ' GLY . 41.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 116.609 -1.662 . . . . 0.0 109.829 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.2 34.17 5.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.537 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.39 68.08 0.92 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -162.77 92.94 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.935 -1.484 . . . . 0.0 107.863 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -156.78 27.74 0.32 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -161.09 48.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.516 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.11 139.77 58.74 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.494 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.39 82.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.197 0.935 . . . . 0.0 109.117 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.74 -3.73 0.24 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -56.06 141.5 39.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.058 0.456 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -166.32 -6.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -74.29 -178.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 122.173 0.987 . . . . 0.0 112.068 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.52 90.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 112.664 -2.062 . . . . 0.0 105.933 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.3 m170 58.04 27.3 14.67 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.248 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.08 -35.66 67.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -52.47 -50.02 63.51 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.268 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -41.72 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.11 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.6 -51.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.91 -48.55 79.57 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.989 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -51.77 46.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.31 61.25 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.089 0.471 . . . . 0.0 110.604 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.94 -47.96 76.6 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -52.88 -51.83 59.7 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.338 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.2 t -50.56 -48.99 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.588 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.18 -55.53 27.81 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -52.24 -47.75 65.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.976 0.893 . . . . 0.0 110.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -51.2 -57.55 8.49 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.575 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.28 -46.71 18.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 123.469 0.481 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.56 -56.04 26.67 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.8 78.87 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.304 0.573 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.5 -53.11 17.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.3 mt -53.58 -48.17 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.72 -51.33 53.42 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.77 -45.18 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.783 -0.208 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.0 mtp -55.22 -53.25 58.41 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -49.4 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 124.77 1.294 . . . . 0.0 109.691 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.16 -57.25 13.63 Favored Glycine 0 N--CA 1.494 2.528 0 O-C-N 124.168 0.918 . . . . 0.0 112.8 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.14 -9.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.22 33.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.599 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.01 97.82 3.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.424 0.631 . . . . 0.0 109.363 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 60.35 4.68 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 123.067 1.413 . . . . 0.0 109.093 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -147.51 59.09 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.047 -2.342 . . . . 0.0 105.023 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 59.05 38.2 24.1 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.545 -1.662 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 75.61 1.41 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -65.45 -158.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.899 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 t -147.95 67.46 1.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.67 36.81 Favored Glycine 0 N--CA 1.499 2.845 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -74.11 133.56 42.83 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.467 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.43 132.99 37.54 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.99 164.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 124.28 0.988 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -78.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.267 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.74 20.93 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.118 0.887 . . . . 0.0 109.807 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -32.04 63.2 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.524 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -53.57 54.46 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.722 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -38.39 86.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.286 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.56 -53.09 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -54.36 -49.48 69.72 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -54.05 29.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.702 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.41 67.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.68 -48.35 77.82 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.028 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -52.25 -51.36 58.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.134 0.896 . . . . 0.0 110.008 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.0 t -52.81 -50.45 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.518 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.08 -54.8 33.67 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.494 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.4 t -76.08 -5.46 46.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.13 -53.09 62.14 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.109 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -50.58 -40.44 52.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.52 -58.58 13.83 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.13 75.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.502 0.667 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.3 mt -53.1 -55.76 10.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.896 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -55.31 -46.64 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.194 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.14 -49.17 60.54 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.92 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -66.05 -33.83 76.7 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 117.703 -1.599 . . . . 0.0 108.799 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.58 -59.19 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.649 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.54 -76.19 1.12 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.34 -68.53 0.07 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.35 57.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 99.8 t . . . . . 0 N--CA 1.496 1.849 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.916 0.389 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.84 26.47 2.62 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.9 48.06 0.87 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.77 75.39 1.27 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.652 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 52.86 72.77 0.39 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.831 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 34.25 39.35 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 115.162 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.88 164.25 10.56 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.411 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p 47.35 -160.11 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.806 1.317 . . . . 0.0 113.365 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.27 -65.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.1 t80 62.22 140.21 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.974 1.044 . . . . 0.0 113.126 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.63 113.54 15.57 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.58 174.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.213 0.946 . . . . 0.0 109.181 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -73.52 0.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.227 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 14.65 0.97 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.245 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.65 -44.27 66.03 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.193 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -53.48 -55.78 22.48 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.6 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.66 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.05 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.44 -52.67 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -57.46 -48.81 78.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.485 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.29 -55.19 23.02 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.046 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.16 -47.29 65.53 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.374 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -55.27 -50.32 69.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.31 -52.34 59.43 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.406 1.098 . . . . 0.0 109.329 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.8 t -51.69 -49.3 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.238 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.81 -45.63 5.85 Favored Glycine 0 N--CA 1.501 2.971 0 O-C-N 124.963 1.414 . . . . 0.0 112.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -82.37 -50.64 8.68 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.885 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -50.42 -48.79 56.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -50.1 -35.91 27.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.53 -57.23 20.88 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.6 -44.15 96.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -53.78 -49.67 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.46 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.69 -45.96 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -53.75 37.27 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.715 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.39 -36.82 85.15 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.072 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.5 tpt -60.84 -45.95 92.46 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.65 -54.42 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.13 -1.395 . . . . 0.0 108.535 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.58 -18.96 0.02 OUTLIER Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.915 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.94 -2.31 13.53 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.683 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.4 31.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.771 0.796 . . . . 0.0 108.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 116.371 -1.776 . . . . 0.0 109.952 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.917 0.389 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.94 135.29 10.26 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.063 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.67 -18.29 61.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 123.778 0.673 . . . . 0.0 110.536 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 57.85 20.84 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.309 1.005 . . . . 0.0 110.871 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.04 37.92 1.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.801 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -154.47 18.18 0.47 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.36 125.67 42.12 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.514 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 t 57.99 42.37 22.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.36 1.038 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.33 -69.47 1.38 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 85.4 t80 -168.57 154.34 6.72 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.559 0.695 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.7 tm-20 -165.27 144.15 6.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.778 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.59 -152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -120.59 -82.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 17.4 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.924 0.765 . . . . 0.0 109.821 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -47.11 -45.85 22.46 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.444 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -60.71 2.88 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.069 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -36.19 83.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.407 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -53.42 -56.07 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -50.8 -49.8 57.63 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.955 0.883 . . . . 0.0 109.225 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.93 -52.33 60.96 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.58 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.49 -45.67 62.9 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.92 -50.78 67.96 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.01 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -51.83 -51.93 52.99 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.042 1.401 . . . . 0.0 109.4 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.92 -48.78 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.348 -2.206 . . . . 0.0 110.625 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.51 -50.64 18.12 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -46.57 -55.82 7.0 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.203 1.001 . . . . 0.0 109.883 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -62.48 -48.93 77.44 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.513 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -44.59 -47.29 10.33 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.915 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.54 -55.21 14.06 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.51 83.24 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.091 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mt -49.13 -49.9 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.998 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.84 -51.86 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.23 35.95 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.42 -53.68 26.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.2 ptm -60.59 -35.8 76.99 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.782 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.42 -50.47 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.71 40.71 2.12 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.27 -32.67 0.48 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.7 t 41.83 36.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.499 1.142 . . . . 0.0 111.475 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.338 -1.792 . . . . 0.0 109.793 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 120.708 0.29 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.6 73.46 5.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.273 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -129.88 47.96 2.44 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.35 68.64 3.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.698 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 64.42 82.0 0.19 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.883 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -88.85 48.97 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.637 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.9 174.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.924 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 t 57.48 37.46 27.77 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.299 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.11 94.08 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.34 -33.54 75.97 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.657 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.96 107.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 125.004 1.44 . . . . 0.0 111.219 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -78.13 -172.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -73.86 0.21 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 11.52 0.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.097 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.38 -45.86 62.61 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.067 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -50.58 -57.3 8.49 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.303 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.63 -38.3 90.52 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.314 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -52.88 -52.22 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.65 -50.88 69.03 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.817 0.818 . . . . 0.0 109.48 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -55.19 26.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.941 -1.482 . . . . 0.0 109.856 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.39 64.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.201 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -53.02 62.93 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -47.53 -53.28 14.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.191 0.996 . . . . 0.0 109.595 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.19 -53.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.86 -49.16 9.16 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -70.25 -65.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.983 -1.108 . . . . 0.0 110.812 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -61.6 -73.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.33 -36.07 13.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.75 -59.37 10.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.48 87.57 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.143 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.54 -56.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.25 -45.6 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -51.55 47.73 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.715 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -39.29 92.83 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 118.459 -1.296 . . . . 0.0 111.135 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.98 80.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.866 0.729 . . . . 0.0 109.406 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.96 -55.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.549 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.15 49.68 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.84 -1.172 . . . . 0.0 111.973 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.69 -35.93 83.68 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.89 48.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.593 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.33 75.32 0.8 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.784 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.16 -18.7 55.22 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 69.02 30.55 4.43 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 124.334 1.022 . . . . 0.0 112.658 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 7' ' ' ASP . 5.9 mpt_? -98.64 63.81 1.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -80.98 33.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.39 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -75.53 134.77 40.67 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.128 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -67.27 143.79 56.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.919 0.762 . . . . 0.0 111.09 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.13 -72.81 1.13 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -157.58 -67.5 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 2.1 tp10 -168.61 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.738 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.45 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.345 0.593 . . . . 0.0 110.324 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -61.23 -89.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 2.84 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.459 0.474 . . . . 0.0 111.298 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -57.49 -43.62 84.29 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.81 0.814 . . . . 0.0 109.051 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 tptm -57.32 -53.19 60.92 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.421 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.76 -39.53 94.43 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.346 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.21 -55.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -60.77 -47.12 87.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.562 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -54.01 38.16 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.091 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.44 -44.48 65.5 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.289 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.51 -52.66 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.28 -52.37 53.2 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.568 1.175 . . . . 0.0 109.646 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.4 -48.83 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 112.735 -2.029 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.57 -51.28 7.99 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 t -67.15 -58.71 4.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.839 -1.18 . . . . 0.0 110.66 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.3 -71.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.498 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.15 -34.8 23.52 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.18 -60.12 9.49 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.15 -44.12 87.7 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.7 mt -53.25 -55.9 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.89 -46.53 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.64 -50.38 49.21 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.38 -48.64 80.85 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.832 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.2 tpt -52.87 -49.47 65.76 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.98 0.8 . . . . 0.0 110.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.13 -53.07 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.65 -113.92 1.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 -29.42 5.8 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.44 36.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.594 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.84 133.17 31.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.975 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' H ' ' CB ' ' A' ' 8' ' ' SER . 30.1 tt0 -81.09 -105.77 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -156.85 88.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.198 0.523 . . . . 0.0 111.807 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 48.66 24.9 0.86 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.888 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 8' ' ' SER . 13.4 t-160 -113.08 -114.23 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' H ' ' CG ' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -75.86 33.32 0.12 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.134 0.896 . . . . 0.0 110.81 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 6' ' ' HIS . 57.7 p -162.47 26.16 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.79 -19.85 0.03 OUTLIER Glycine 0 N--CA 1.498 2.82 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.126 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -83.65 -142.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -168.74 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 18' ' ' VAL . 12.4 m -139.19 -165.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.555 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -153.21 5.62 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 111.067 -2.788 . . . . 0.0 104.443 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -156.31 128.61 7.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -59.72 -12.59 7.39 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 0.0 111.237 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -69.06 -51.12 42.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -59.46 -34.92 73.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.885 -1.962 . . . . 0.0 107.489 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' N ' HG13 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -59.14 -57.2 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -48.7 -49.66 36.9 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.741 0.781 . . . . 0.0 109.784 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -54.53 -53.44 54.44 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.174 -1.376 . . . . 0.0 108.594 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.05 61.88 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.557 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.0 -51.76 68.34 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.2 -54.0 14.97 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.62 1.2 . . . . 0.0 109.428 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.7 t -53.95 -53.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.684 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.87 -51.25 18.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -62.59 -60.53 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.575 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -58.53 -70.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.044 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -35.82 30.29 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.49 -59.21 11.27 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.0 mt -51.73 -55.64 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.709 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.75 -47.42 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -50.2 47.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 mt -58.88 -48.97 79.52 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.669 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 mtt -53.97 -50.04 67.42 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.913 0.758 . . . . 0.0 110.307 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.24 -50.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.344 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.43 -55.21 27.99 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.88 -33.67 3.93 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.94 27.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.193 -1.861 . . . . 0.0 107.735 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.178 0 CA-C-O 121.412 0.625 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -23.69 67.4 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -60.6 -43.06 97.86 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -67.38 -43.68 80.78 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -52.5 -52.09 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -57.99 -46.59 84.96 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.64 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.04 -51.92 54.34 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.41 -46.77 66.48 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.58 -49.55 76.02 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.205 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -49.6 -53.3 24.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.552 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 20' ' ' PHE . 88.3 t -54.12 -53.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.085 -1.871 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.89 -54.52 17.9 Favored Glycine 0 N--CA 1.496 2.68 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.546 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -64.47 -51.45 63.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -41.92 -45.46 3.75 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.053 -0.976 . . . . 0.0 113.138 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -36.6 -39.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.463 1.102 . . . . 0.0 112.798 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.37 -58.1 15.0 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.93 83.54 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.104 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -53.64 -54.28 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.153 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.2 mt -54.87 -47.6 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.99 -49.63 54.56 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.0 -48.58 79.6 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.642 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.4 mtp -52.0 -49.67 62.87 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.155 0.909 . . . . 0.0 109.516 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.0 -53.19 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.719 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.11 137.91 4.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.41 97.92 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.83 33.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.109 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -14.22 3.08 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.26 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -74.89 -57.14 4.09 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -37.43 78.51 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.486 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.42 -53.26 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.31 -49.46 69.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -55.51 -54.96 37.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.98 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.62 -45.6 63.31 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.478 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -56.91 -52.26 65.86 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -50.76 -52.27 42.32 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.085 1.421 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 20' ' ' PHE . 48.0 t -54.64 -50.8 56.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.982 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.35 -56.49 23.16 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.154 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -53.41 -47.71 69.35 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.65 -59.59 4.4 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.618 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -50.97 -44.59 60.66 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.065 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.38 -55.0 30.67 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.73 80.52 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -51.31 -54.29 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.351 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.91 -48.45 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.96 58.29 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.79 -47.89 81.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -52.34 -54.49 31.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.771 0.67 . . . . 0.0 109.227 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.85 -53.65 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 125.182 1.551 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.53 61.99 0.29 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -159.17 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.67 29.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.098 0.951 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLY . 55.3 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 116.441 -1.742 . . . . 0.0 109.76 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 122.106 0.955 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -48.06 -32.4 6.69 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.435 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -53.18 54.55 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.456 0.646 . . . . 0.0 110.601 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.29 -36.44 79.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.207 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG12 ' OE2' ' A' ' 22' ' ' GLU . 89.3 t -53.68 -49.7 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -55.97 -49.51 73.36 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.695 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.27 -55.51 20.85 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.822 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.04 -46.51 68.49 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.646 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' OE2' HG12 ' A' ' 18' ' ' VAL . 25.1 mt-10 -56.61 -49.54 74.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -52.91 -53.41 49.67 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.203 1.001 . . . . 0.0 109.207 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 20' ' ' PHE . 63.4 t -49.59 -51.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.15 -54.39 35.94 Favored Glycine 0 N--CA 1.498 2.811 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -50.36 -51.79 42.81 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.708 0.766 . . . . 0.0 110.617 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -54.13 -62.49 1.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.458 -1.247 . . . . 0.0 113.432 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -55.36 -37.61 67.73 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.168 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.27 -56.67 23.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.84 77.41 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.735 0.778 . . . . 0.0 110.821 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.2 mt -53.64 -56.89 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.311 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.9 mt -55.88 -41.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.75 -53.49 39.01 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -38.23 86.65 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtp -60.35 -52.89 63.31 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.49 -47.19 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.592 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.42 3.59 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.287 0.992 . . . . 0.0 113.112 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.88 32.32 24.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.23 23.57 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.773 0.796 . . . . 0.0 109.982 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 116.609 -1.662 . . . . 0.0 109.829 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.435 ' HB3' HD23 ' A' ' 17' ' ' LEU . 6.3 m170 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.94 0.876 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -35.66 67.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -52.47 -50.02 63.51 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.268 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -66.67 -41.72 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.11 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.6 -51.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.91 -48.55 79.57 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.989 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -50.71 -51.77 46.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.31 61.25 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.089 0.471 . . . . 0.0 110.604 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.94 -47.96 76.6 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -52.88 -51.83 59.7 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.338 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' PHE . 71.2 t -50.56 -48.99 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.588 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.18 -55.53 27.81 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -52.24 -47.75 65.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.976 0.893 . . . . 0.0 110.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -51.2 -57.55 8.49 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.575 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.28 -46.71 18.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 123.469 0.481 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.56 -56.04 26.67 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.8 78.87 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.304 0.573 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.5 -53.11 17.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.3 mt -53.58 -48.17 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.72 -51.33 53.42 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.77 -45.18 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.783 -0.208 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.0 mtp -55.22 -53.25 58.41 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -49.4 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 124.77 1.294 . . . . 0.0 109.691 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.16 -57.25 13.63 Favored Glycine 0 N--CA 1.494 2.528 0 O-C-N 124.168 0.918 . . . . 0.0 112.8 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.14 -9.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.22 33.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.599 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.887 0.851 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -32.04 63.2 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.524 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -53.57 54.46 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.722 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -66.74 -38.39 86.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.286 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.56 -53.09 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -54.36 -49.48 69.72 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.72 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -51.2 -54.05 29.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.702 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.41 67.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.68 -48.35 77.82 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.028 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -52.25 -51.36 58.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.134 0.896 . . . . 0.0 110.008 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 20' ' ' PHE . 66.0 t -52.81 -50.45 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.518 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.08 -54.8 33.67 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.494 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.4 t -76.08 -5.46 46.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.13 -53.09 62.14 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.109 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -50.58 -40.44 52.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.52 -58.58 13.83 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.13 75.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.502 0.667 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.3 mt -53.1 -55.76 10.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.896 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -55.31 -46.64 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.194 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.14 -49.17 60.54 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.92 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -66.05 -33.83 76.7 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 117.703 -1.599 . . . . 0.0 108.799 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.58 -59.19 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.649 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.54 -76.19 1.12 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.34 -68.53 0.07 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.35 57.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 99.8 t . . . . . 0 N--CA 1.496 1.849 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.707 0.765 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -52.65 -44.27 66.03 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.193 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -53.48 -55.78 22.48 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.6 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.66 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.05 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.44 -52.67 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -57.46 -48.81 78.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.485 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.74 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -52.29 -55.19 23.02 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.046 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.16 -47.29 65.53 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.374 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -55.27 -50.32 69.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.31 -52.34 59.43 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.406 1.098 . . . . 0.0 109.329 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 20' ' ' PHE . 58.8 t -51.69 -49.3 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.238 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.81 -45.63 5.85 Favored Glycine 0 N--CA 1.501 2.971 0 O-C-N 124.963 1.414 . . . . 0.0 112.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -82.37 -50.64 8.68 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.885 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -50.42 -48.79 56.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -50.1 -35.91 27.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.53 -57.23 20.88 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.6 -44.15 96.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -53.78 -49.67 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.46 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.69 -45.96 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -53.75 37.27 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.715 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.39 -36.82 85.15 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.072 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.5 tpt -60.84 -45.95 92.46 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.65 -54.42 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.13 -1.395 . . . . 0.0 108.535 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.58 -18.96 0.02 OUTLIER Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.915 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.94 -2.31 13.53 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.683 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.4 31.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.771 0.796 . . . . 0.0 108.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 116.371 -1.776 . . . . 0.0 109.952 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -47.11 -45.85 22.46 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.444 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -60.71 2.88 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.069 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -64.15 -36.19 83.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.407 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -53.42 -56.07 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -50.8 -49.8 57.63 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.955 0.883 . . . . 0.0 109.225 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -53.93 -52.33 60.96 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.58 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.49 -45.67 62.9 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.92 -50.78 67.96 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.01 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -51.83 -51.93 52.99 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.042 1.401 . . . . 0.0 109.4 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 20' ' ' PHE . 39.4 t -53.92 -48.78 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.348 -2.206 . . . . 0.0 110.625 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.51 -50.64 18.12 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -46.57 -55.82 7.0 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.203 1.001 . . . . 0.0 109.883 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -62.48 -48.93 77.44 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.513 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -44.59 -47.29 10.33 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.915 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.54 -55.21 14.06 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.51 83.24 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.091 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mt -49.13 -49.9 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.998 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.84 -51.86 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.23 35.95 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.42 -53.68 26.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.2 ptm -60.59 -35.8 76.99 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.782 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.42 -50.47 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.71 40.71 2.12 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.27 -32.67 0.48 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 39' ' ' VAL . 71.7 t 41.83 36.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.499 1.142 . . . . 0.0 111.475 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.338 -1.792 . . . . 0.0 109.793 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.669 0.747 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.38 -45.86 62.61 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.067 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -50.58 -57.3 8.49 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.303 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.63 -38.3 90.52 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.314 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -52.88 -52.22 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.65 -50.88 69.03 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.817 0.818 . . . . 0.0 109.48 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -53.26 -55.19 26.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.941 -1.482 . . . . 0.0 109.856 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.39 64.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.201 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -53.02 62.93 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -47.53 -53.28 14.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.191 0.996 . . . . 0.0 109.595 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 20' ' ' PHE . 93.6 t -55.19 -53.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.86 -49.16 9.16 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -70.25 -65.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.983 -1.108 . . . . 0.0 110.812 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -61.6 -73.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.33 -36.07 13.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.75 -59.37 10.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.48 87.57 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.143 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.54 -56.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.25 -45.6 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -51.55 47.73 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.715 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -39.29 92.83 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 118.459 -1.296 . . . . 0.0 111.135 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.98 80.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.866 0.729 . . . . 0.0 109.406 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.96 -55.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.549 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.15 49.68 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.84 -1.172 . . . . 0.0 111.973 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.69 -35.93 83.68 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.89 48.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.593 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.761 0.315 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -57.49 -43.62 84.29 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.81 0.814 . . . . 0.0 109.051 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 tptm -57.32 -53.19 60.92 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.421 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -62.76 -39.53 94.43 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.346 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.21 -55.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -60.77 -47.12 87.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.562 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.49 -54.01 38.16 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.091 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.44 -44.48 65.5 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.289 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.51 -52.66 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.28 -52.37 53.2 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.568 1.175 . . . . 0.0 109.646 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.9 t -53.4 -48.83 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 112.735 -2.029 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.57 -51.28 7.99 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 t -67.15 -58.71 4.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.839 -1.18 . . . . 0.0 110.66 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.3 -71.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.498 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.15 -34.8 23.52 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.18 -60.12 9.49 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.15 -44.12 87.7 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.7 mt -53.25 -55.9 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.89 -46.53 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.64 -50.38 49.21 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.38 -48.64 80.85 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.832 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.2 tpt -52.87 -49.47 65.76 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.98 0.8 . . . . 0.0 110.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.13 -53.07 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.65 -113.92 1.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 -29.42 5.8 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.44 36.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.594 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -59.72 -12.59 7.39 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 0.0 111.237 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -69.06 -51.12 42.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -59.46 -34.92 73.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.885 -1.962 . . . . 0.0 107.489 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.14 -57.2 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -48.7 -49.66 36.9 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.741 0.781 . . . . 0.0 109.784 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.3 t80 -54.53 -53.44 54.44 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.174 -1.376 . . . . 0.0 108.594 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.05 61.88 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.557 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.0 -51.76 68.34 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.2 -54.0 14.97 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.62 1.2 . . . . 0.0 109.428 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 20' ' ' PHE . 83.7 t -53.95 -53.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.684 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.87 -51.25 18.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -62.59 -60.53 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.575 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -58.53 -70.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.044 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -35.82 30.29 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.49 -59.21 11.27 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.0 mt -51.73 -55.64 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.709 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.75 -47.42 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -50.2 47.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 mt -58.88 -48.97 79.52 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.669 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 mtt -53.97 -50.04 67.42 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.913 0.758 . . . . 0.0 110.307 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.24 -50.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.344 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.43 -55.21 27.99 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.88 -33.67 3.93 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.94 27.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.193 -1.861 . . . . 0.0 107.735 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.711 ' HB1' ' H ' ' A' ' 6' ' ' HIS . . . -84.19 103.51 13.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.28 -19.88 64.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 123.954 0.784 . . . . 0.0 108.941 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.6 t80 176.64 103.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 41.61 61.28 1.9 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 121.117 0.484 . . . . 0.0 112.088 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.711 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 28.0 p80 38.85 35.19 0.11 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.07 154.98 14.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 p -73.06 157.38 37.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.957 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.64 84.55 0.05 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -54.14 -25.17 20.87 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.481 0.753 . . . . 0.0 110.609 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 69.64 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.224 1.578 . . . . 0.0 111.38 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.583 HG21 ' CB ' ' A' ' 15' ' ' GLN . 23.6 m -139.9 -166.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.117 0.484 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -74.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 -4.22 2.92 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 123.798 0.686 . . . . 0.0 112.091 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' CB ' HG21 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -64.2 -23.69 67.4 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -60.6 -43.06 97.86 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -67.38 -43.68 80.78 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -52.5 -52.09 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -57.99 -46.59 84.96 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.64 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.04 -51.92 54.34 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.41 -46.77 66.48 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.58 -49.55 76.02 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.205 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -49.6 -53.3 24.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.552 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 20' ' ' PHE . 88.3 t -54.12 -53.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.085 -1.871 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.89 -54.52 17.9 Favored Glycine 0 N--CA 1.496 2.68 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.546 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -64.47 -51.45 63.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -41.92 -45.46 3.75 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.053 -0.976 . . . . 0.0 113.138 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -36.6 -39.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.463 1.102 . . . . 0.0 112.798 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.37 -58.1 15.0 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.93 83.54 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.104 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -53.64 -54.28 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.153 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.2 mt -54.87 -47.6 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.99 -49.63 54.56 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.0 -48.58 79.6 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.642 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.4 mtp -52.0 -49.67 62.87 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.155 0.909 . . . . 0.0 109.516 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.0 -53.19 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.719 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.11 137.91 4.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.41 97.92 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.83 33.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.109 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . . . -95.21 60.54 2.33 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 53.33 37.47 25.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.049 -1.887 . . . . 0.0 112.393 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 23.9 m-85 -112.94 26.04 10.86 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.268 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 46.36 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 p80 38.25 29.04 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.698 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.64 117.3 1.12 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.589 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.465 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 21.7 m -158.56 166.91 30.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.912 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 69.19 0.02 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.06 170.97 19.44 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -86.07 119.96 26.93 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.612 HG13 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -112.14 172.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 18.5 m-70 -83.67 28.3 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.455 ' H ' HG22 ' A' ' 12' ' ' VAL . 99.0 m-70 -151.09 109.28 3.74 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -14.22 3.08 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.26 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -74.89 -57.14 4.09 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' CB ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -59.59 -37.43 78.51 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.486 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.612 HG23 HG13 ' A' ' 12' ' ' VAL . 11.2 t -53.42 -53.26 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.31 -49.46 69.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -55.51 -54.96 37.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.98 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.62 -45.6 63.31 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.478 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -56.91 -52.26 65.86 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -50.76 -52.27 42.32 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.085 1.421 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 20' ' ' PHE . 48.0 t -54.64 -50.8 56.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.982 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.35 -56.49 23.16 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.154 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -53.41 -47.71 69.35 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.65 -59.59 4.4 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.618 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -50.97 -44.59 60.66 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.065 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.38 -55.0 30.67 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.73 80.52 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -51.31 -54.29 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.351 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.91 -48.45 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.96 58.29 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.79 -47.89 81.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -52.34 -54.49 31.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.771 0.67 . . . . 0.0 109.227 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.85 -53.65 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 125.182 1.551 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.53 61.99 0.29 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -159.17 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.67 29.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.098 0.951 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLY . 55.3 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 116.441 -1.742 . . . . 0.0 109.76 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.03 147.52 11.34 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.81 -40.41 95.14 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.9 t80 60.67 99.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.897 1.373 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -135.16 26.74 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.594 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -87.92 42.81 1.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.668 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.54 80.38 2.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.146 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -143.52 131.39 21.53 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.434 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.64 -57.21 0.48 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.03 156.4 37.54 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -135.14 128.36 31.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.31 162.25 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 122.594 1.188 . . . . 0.0 113.577 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -115.53 65.6 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.006 -2.361 . . . . 0.0 106.731 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 53.67 31.52 12.88 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.222 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -48.06 -32.4 6.69 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.435 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -53.18 54.55 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.456 0.646 . . . . 0.0 110.601 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.29 -36.44 79.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.207 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG12 ' OE2' ' A' ' 22' ' ' GLU . 89.3 t -53.68 -49.7 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -55.97 -49.51 73.36 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.695 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.27 -55.51 20.85 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.822 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.04 -46.51 68.49 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.646 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' OE2' HG12 ' A' ' 18' ' ' VAL . 25.1 mt-10 -56.61 -49.54 74.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -52.91 -53.41 49.67 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.203 1.001 . . . . 0.0 109.207 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 20' ' ' PHE . 63.4 t -49.59 -51.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.15 -54.39 35.94 Favored Glycine 0 N--CA 1.498 2.811 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -50.36 -51.79 42.81 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.708 0.766 . . . . 0.0 110.617 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -54.13 -62.49 1.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.458 -1.247 . . . . 0.0 113.432 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -55.36 -37.61 67.73 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.168 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.27 -56.67 23.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.84 77.41 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.735 0.778 . . . . 0.0 110.821 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.2 mt -53.64 -56.89 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.311 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.9 mt -55.88 -41.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.75 -53.49 39.01 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -38.23 86.65 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtp -60.35 -52.89 63.31 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.49 -47.19 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.592 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.42 3.59 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.287 0.992 . . . . 0.0 113.112 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.88 32.32 24.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.23 23.57 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.773 0.796 . . . . 0.0 109.982 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 116.609 -1.662 . . . . 0.0 109.829 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.2 34.17 5.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.537 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.39 68.08 0.92 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -162.77 92.94 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.935 -1.484 . . . . 0.0 107.863 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -156.78 27.74 0.32 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -161.09 48.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.516 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.11 139.77 58.74 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.494 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.39 82.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.197 0.935 . . . . 0.0 109.117 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.74 -3.73 0.24 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -56.06 141.5 39.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.058 0.456 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -166.32 -6.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -74.29 -178.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 122.173 0.987 . . . . 0.0 112.068 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -152.52 90.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 112.664 -2.062 . . . . 0.0 105.933 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.435 ' HB3' HD23 ' A' ' 17' ' ' LEU . 7.1 m-70 58.04 27.3 14.67 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.248 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.08 -35.66 67.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -52.47 -50.02 63.51 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.268 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -66.67 -41.72 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.11 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.6 -51.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.91 -48.55 79.57 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.989 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -50.71 -51.77 46.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.31 61.25 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.089 0.471 . . . . 0.0 110.604 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.94 -47.96 76.6 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -52.88 -51.83 59.7 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.338 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' PHE . 71.2 t -50.56 -48.99 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.588 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.18 -55.53 27.81 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -52.24 -47.75 65.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.976 0.893 . . . . 0.0 110.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -51.2 -57.55 8.49 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.575 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.28 -46.71 18.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 123.469 0.481 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.56 -56.04 26.67 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.8 78.87 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.304 0.573 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.5 -53.11 17.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.3 mt -53.58 -48.17 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.72 -51.33 53.42 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.77 -45.18 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.783 -0.208 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.0 mtp -55.22 -53.25 58.41 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -49.4 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 124.77 1.294 . . . . 0.0 109.691 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.16 -57.25 13.63 Favored Glycine 0 N--CA 1.494 2.528 0 O-C-N 124.168 0.918 . . . . 0.0 112.8 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.14 -9.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.22 33.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.599 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.01 97.82 3.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.424 0.631 . . . . 0.0 109.363 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 60.35 4.68 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 123.067 1.413 . . . . 0.0 109.093 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -147.51 59.09 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.047 -2.342 . . . . 0.0 105.023 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 59.05 38.2 24.1 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.545 -1.662 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 75.61 1.41 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -65.45 -158.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.899 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 t -147.95 67.46 1.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.67 36.81 Favored Glycine 0 N--CA 1.499 2.845 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -74.11 133.56 42.83 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.467 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.43 132.99 37.54 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.99 164.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 124.28 0.988 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -78.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.267 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.74 20.93 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.118 0.887 . . . . 0.0 109.807 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -32.04 63.2 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.524 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -53.57 54.46 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.722 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -66.74 -38.39 86.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.286 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.56 -53.09 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -54.36 -49.48 69.72 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.72 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -51.2 -54.05 29.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.702 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.41 67.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.68 -48.35 77.82 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.028 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -52.25 -51.36 58.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.134 0.896 . . . . 0.0 110.008 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 20' ' ' PHE . 66.0 t -52.81 -50.45 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.518 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.08 -54.8 33.67 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.494 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.4 t -76.08 -5.46 46.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.13 -53.09 62.14 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.109 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -50.58 -40.44 52.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.52 -58.58 13.83 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.13 75.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.502 0.667 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.3 mt -53.1 -55.76 10.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.896 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -55.31 -46.64 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.194 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.14 -49.17 60.54 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.92 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -66.05 -33.83 76.7 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 117.703 -1.599 . . . . 0.0 108.799 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.58 -59.19 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.649 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.54 -76.19 1.12 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.34 -68.53 0.07 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.35 57.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 99.8 t . . . . . 0 N--CA 1.496 1.849 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.916 0.389 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.84 26.47 2.62 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.9 48.06 0.87 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.77 75.39 1.27 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.652 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 52.86 72.77 0.39 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.831 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 34.25 39.35 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 115.162 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.88 164.25 10.56 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.411 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p 47.35 -160.11 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.806 1.317 . . . . 0.0 113.365 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.27 -65.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.1 t80 62.22 140.21 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.974 1.044 . . . . 0.0 113.126 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.63 113.54 15.57 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.58 174.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.213 0.946 . . . . 0.0 109.181 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -73.52 0.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.227 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.407 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -148.56 14.65 0.97 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.245 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' NE2' ' H ' ' A' ' 14' ' ' HIS . 1.8 mp0 -52.65 -44.27 66.03 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.193 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -53.48 -55.78 22.48 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.6 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.66 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.05 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.44 -52.67 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -57.46 -48.81 78.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.485 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.74 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -52.29 -55.19 23.02 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.046 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.16 -47.29 65.53 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.374 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -55.27 -50.32 69.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.31 -52.34 59.43 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.406 1.098 . . . . 0.0 109.329 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 20' ' ' PHE . 58.8 t -51.69 -49.3 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.238 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.81 -45.63 5.85 Favored Glycine 0 N--CA 1.501 2.971 0 O-C-N 124.963 1.414 . . . . 0.0 112.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -82.37 -50.64 8.68 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.885 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -50.42 -48.79 56.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -50.1 -35.91 27.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.53 -57.23 20.88 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.6 -44.15 96.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -53.78 -49.67 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.46 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.69 -45.96 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -53.75 37.27 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.715 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.39 -36.82 85.15 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.072 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.5 tpt -60.84 -45.95 92.46 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.65 -54.42 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.13 -1.395 . . . . 0.0 108.535 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.58 -18.96 0.02 OUTLIER Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.915 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.94 -2.31 13.53 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.683 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.4 31.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.771 0.796 . . . . 0.0 108.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 116.371 -1.776 . . . . 0.0 109.952 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.917 0.389 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.94 135.29 10.26 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.063 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.67 -18.29 61.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 123.778 0.673 . . . . 0.0 110.536 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 57.85 20.84 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.309 1.005 . . . . 0.0 110.871 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.04 37.92 1.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.801 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -154.47 18.18 0.47 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.36 125.67 42.12 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.514 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 t 57.99 42.37 22.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.36 1.038 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.33 -69.47 1.38 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 85.4 t80 -168.57 154.34 6.72 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.559 0.695 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.7 tm-20 -165.27 144.15 6.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.778 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.59 -152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -120.59 -82.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 17.4 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.924 0.765 . . . . 0.0 109.821 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -47.11 -45.85 22.46 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.444 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -60.71 2.88 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.069 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -64.15 -36.19 83.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.407 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -53.42 -56.07 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -50.8 -49.8 57.63 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.955 0.883 . . . . 0.0 109.225 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -53.93 -52.33 60.96 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.58 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.49 -45.67 62.9 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.92 -50.78 67.96 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.01 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -51.83 -51.93 52.99 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.042 1.401 . . . . 0.0 109.4 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 20' ' ' PHE . 39.4 t -53.92 -48.78 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.348 -2.206 . . . . 0.0 110.625 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.51 -50.64 18.12 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -46.57 -55.82 7.0 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.203 1.001 . . . . 0.0 109.883 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -62.48 -48.93 77.44 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.513 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -44.59 -47.29 10.33 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.915 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.54 -55.21 14.06 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.51 83.24 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.091 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mt -49.13 -49.9 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.998 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.84 -51.86 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.23 35.95 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.42 -53.68 26.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.2 ptm -60.59 -35.8 76.99 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.782 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.42 -50.47 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.71 40.71 2.12 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.27 -32.67 0.48 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 39' ' ' VAL . 71.7 t 41.83 36.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.499 1.142 . . . . 0.0 111.475 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.338 -1.792 . . . . 0.0 109.793 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 120.708 0.29 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.6 73.46 5.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.273 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -129.88 47.96 2.44 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.35 68.64 3.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.698 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 64.42 82.0 0.19 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.883 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -88.85 48.97 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.637 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.9 174.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.924 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 t 57.48 37.46 27.77 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.299 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.11 94.08 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.34 -33.54 75.97 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.657 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.96 107.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 125.004 1.44 . . . . 0.0 111.219 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -78.13 -172.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -73.86 0.21 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 11.52 0.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.097 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.38 -45.86 62.61 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.067 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -50.58 -57.3 8.49 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.303 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.63 -38.3 90.52 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.314 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -52.88 -52.22 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.65 -50.88 69.03 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.817 0.818 . . . . 0.0 109.48 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -53.26 -55.19 26.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.941 -1.482 . . . . 0.0 109.856 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.39 64.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.201 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -53.02 62.93 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -47.53 -53.28 14.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.191 0.996 . . . . 0.0 109.595 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 20' ' ' PHE . 93.6 t -55.19 -53.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.86 -49.16 9.16 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -70.25 -65.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.983 -1.108 . . . . 0.0 110.812 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -61.6 -73.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.33 -36.07 13.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.75 -59.37 10.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.48 87.57 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.143 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.54 -56.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.25 -45.6 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -51.55 47.73 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.715 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -39.29 92.83 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 118.459 -1.296 . . . . 0.0 111.135 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.98 80.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.866 0.729 . . . . 0.0 109.406 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.96 -55.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.549 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.15 49.68 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.84 -1.172 . . . . 0.0 111.973 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.69 -35.93 83.68 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.89 48.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.593 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.33 75.32 0.8 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.784 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.16 -18.7 55.22 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 23.9 m-85 69.02 30.55 4.43 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 124.334 1.022 . . . . 0.0 112.658 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -98.64 63.81 1.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 4' ' ' PHE . 6.8 m-70 -80.98 33.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.39 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.53 134.77 40.67 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.128 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -67.27 143.79 56.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.919 0.762 . . . . 0.0 111.09 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.13 -72.81 1.13 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -157.58 -67.5 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 2.1 tp10 -168.61 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.738 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.493 HG13 ' CE2' ' A' ' 10' ' ' TYR . 19.6 m -74.45 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.345 0.593 . . . . 0.0 110.324 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -61.23 -89.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 2.84 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.459 0.474 . . . . 0.0 111.298 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -57.49 -43.62 84.29 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.81 0.814 . . . . 0.0 109.051 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 tptm -57.32 -53.19 60.92 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.421 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -62.76 -39.53 94.43 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.346 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.21 -55.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -60.77 -47.12 87.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.562 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.49 -54.01 38.16 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.091 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.44 -44.48 65.5 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.289 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.51 -52.66 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.28 -52.37 53.2 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.568 1.175 . . . . 0.0 109.646 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.9 t -53.4 -48.83 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 112.735 -2.029 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.57 -51.28 7.99 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 t -67.15 -58.71 4.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.839 -1.18 . . . . 0.0 110.66 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.3 -71.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.498 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.15 -34.8 23.52 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.18 -60.12 9.49 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.15 -44.12 87.7 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.7 mt -53.25 -55.9 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.89 -46.53 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.64 -50.38 49.21 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.38 -48.64 80.85 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.832 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.2 tpt -52.87 -49.47 65.76 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.98 0.8 . . . . 0.0 110.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.13 -53.07 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.65 -113.92 1.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 -29.42 5.8 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.44 36.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.594 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.84 133.17 31.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.975 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' H ' ' CB ' ' A' ' 8' ' ' SER . 30.1 tt0 -81.09 -105.77 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -156.85 88.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.198 0.523 . . . . 0.0 111.807 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 48.66 24.9 0.86 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.888 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.476 ' C ' ' H ' ' A' ' 8' ' ' SER . 13.4 t-160 -113.08 -114.23 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.86 33.32 0.12 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.134 0.896 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 6' ' ' HIS . 57.7 p -162.47 26.16 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.79 -19.85 0.03 OUTLIER Glycine 0 N--CA 1.498 2.82 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.126 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -83.65 -142.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -168.74 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 18' ' ' VAL . 12.4 m -139.19 -165.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.555 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -153.21 5.62 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 111.067 -2.788 . . . . 0.0 104.443 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -156.31 128.61 7.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -59.72 -12.59 7.39 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 0.0 111.237 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -69.06 -51.12 42.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 38.7 mt -59.46 -34.92 73.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.885 -1.962 . . . . 0.0 107.489 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' N ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -59.14 -57.2 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -48.7 -49.66 36.9 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.741 0.781 . . . . 0.0 109.784 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.3 t80 -54.53 -53.44 54.44 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.174 -1.376 . . . . 0.0 108.594 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.05 61.88 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.557 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.0 -51.76 68.34 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.2 -54.0 14.97 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.62 1.2 . . . . 0.0 109.428 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 20' ' ' PHE . 83.7 t -53.95 -53.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.684 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.87 -51.25 18.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -62.59 -60.53 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.575 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -58.53 -70.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.044 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -35.82 30.29 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.49 -59.21 11.27 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.0 mt -51.73 -55.64 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.709 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.75 -47.42 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -50.2 47.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 mt -58.88 -48.97 79.52 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.669 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 mtt -53.97 -50.04 67.42 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.913 0.758 . . . . 0.0 110.307 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.24 -50.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.344 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.43 -55.21 27.99 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.88 -33.67 3.93 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.94 27.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.193 -1.861 . . . . 0.0 107.735 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.178 0 CA-C-O 121.412 0.625 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -23.69 67.4 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -60.6 -43.06 97.86 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -67.38 -43.68 80.78 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -52.5 -52.09 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -57.99 -46.59 84.96 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.64 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.04 -51.92 54.34 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.41 -46.77 66.48 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.58 -49.55 76.02 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.205 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -49.6 -53.3 24.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.552 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 20' ' ' PHE . 88.3 t -54.12 -53.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.085 -1.871 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.89 -54.52 17.9 Favored Glycine 0 N--CA 1.496 2.68 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.546 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -64.47 -51.45 63.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -41.92 -45.46 3.75 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.053 -0.976 . . . . 0.0 113.138 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -36.6 -39.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.463 1.102 . . . . 0.0 112.798 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.37 -58.1 15.0 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.93 83.54 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.104 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -53.64 -54.28 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.153 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.2 mt -54.87 -47.6 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.99 -49.63 54.56 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.0 -48.58 79.6 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.642 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.4 mtp -52.0 -49.67 62.87 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.155 0.909 . . . . 0.0 109.516 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.0 -53.19 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.719 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.11 137.91 4.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.41 97.92 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.83 33.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.109 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -14.22 3.08 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.26 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -74.89 -57.14 4.09 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.59 -37.43 78.51 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.486 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.42 -53.26 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.31 -49.46 69.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -55.51 -54.96 37.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.98 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.62 -45.6 63.31 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.478 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -56.91 -52.26 65.86 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -50.76 -52.27 42.32 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.085 1.421 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 20' ' ' PHE . 48.0 t -54.64 -50.8 56.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.982 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.35 -56.49 23.16 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.154 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -53.41 -47.71 69.35 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.65 -59.59 4.4 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.618 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -50.97 -44.59 60.66 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.065 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.38 -55.0 30.67 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.73 80.52 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -51.31 -54.29 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.351 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.91 -48.45 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.96 58.29 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.79 -47.89 81.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -52.34 -54.49 31.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.771 0.67 . . . . 0.0 109.227 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.85 -53.65 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 125.182 1.551 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.53 61.99 0.29 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -159.17 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.67 29.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.098 0.951 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLY . 55.3 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 116.441 -1.742 . . . . 0.0 109.76 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 122.106 0.955 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -48.06 -32.4 6.69 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.435 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -53.18 54.55 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.456 0.646 . . . . 0.0 110.601 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.29 -36.44 79.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.207 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG12 ' OE2' ' A' ' 22' ' ' GLU . 89.3 t -53.68 -49.7 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -55.97 -49.51 73.36 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.695 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.27 -55.51 20.85 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.822 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.04 -46.51 68.49 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.646 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' OE2' HG12 ' A' ' 18' ' ' VAL . 25.1 mt-10 -56.61 -49.54 74.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -52.91 -53.41 49.67 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.203 1.001 . . . . 0.0 109.207 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 20' ' ' PHE . 63.4 t -49.59 -51.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.15 -54.39 35.94 Favored Glycine 0 N--CA 1.498 2.811 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -50.36 -51.79 42.81 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.708 0.766 . . . . 0.0 110.617 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.13 -62.49 1.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.458 -1.247 . . . . 0.0 113.432 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -55.36 -37.61 67.73 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.168 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.27 -56.67 23.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.84 77.41 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.735 0.778 . . . . 0.0 110.821 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.2 mt -53.64 -56.89 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.311 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.9 mt -55.88 -41.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.75 -53.49 39.01 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -38.23 86.65 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtp -60.35 -52.89 63.31 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.49 -47.19 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.592 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.42 3.59 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.287 0.992 . . . . 0.0 113.112 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.88 32.32 24.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.23 23.57 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.773 0.796 . . . . 0.0 109.982 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 116.609 -1.662 . . . . 0.0 109.829 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.435 ' HB3' HD23 ' A' ' 17' ' ' LEU . 6.3 m170 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.94 0.876 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.08 -35.66 67.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -52.47 -50.02 63.51 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.268 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -66.67 -41.72 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.11 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.6 -51.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.91 -48.55 79.57 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.989 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -50.71 -51.77 46.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.31 61.25 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.089 0.471 . . . . 0.0 110.604 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.94 -47.96 76.6 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -52.88 -51.83 59.7 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.338 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' PHE . 71.2 t -50.56 -48.99 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.588 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.18 -55.53 27.81 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -52.24 -47.75 65.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.976 0.893 . . . . 0.0 110.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -51.2 -57.55 8.49 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.575 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.28 -46.71 18.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 123.469 0.481 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.56 -56.04 26.67 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.8 78.87 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.304 0.573 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.5 -53.11 17.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.3 mt -53.58 -48.17 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.72 -51.33 53.42 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.77 -45.18 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.783 -0.208 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.0 mtp -55.22 -53.25 58.41 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -49.4 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 124.77 1.294 . . . . 0.0 109.691 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.16 -57.25 13.63 Favored Glycine 0 N--CA 1.494 2.528 0 O-C-N 124.168 0.918 . . . . 0.0 112.8 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.14 -9.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.22 33.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.599 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.887 0.851 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -32.04 63.2 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.524 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -53.57 54.46 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.722 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -66.74 -38.39 86.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.286 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.56 -53.09 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -54.36 -49.48 69.72 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.72 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -51.2 -54.05 29.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.702 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.41 67.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.68 -48.35 77.82 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.028 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -52.25 -51.36 58.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.134 0.896 . . . . 0.0 110.008 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 20' ' ' PHE . 66.0 t -52.81 -50.45 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.518 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.08 -54.8 33.67 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.494 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.4 t -76.08 -5.46 46.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.13 -53.09 62.14 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.109 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -50.58 -40.44 52.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.52 -58.58 13.83 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.13 75.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.502 0.667 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.3 mt -53.1 -55.76 10.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.896 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -55.31 -46.64 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.194 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.14 -49.17 60.54 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.92 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -66.05 -33.83 76.7 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 117.703 -1.599 . . . . 0.0 108.799 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.58 -59.19 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.649 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.54 -76.19 1.12 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.34 -68.53 0.07 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.35 57.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 99.8 t . . . . . 0 N--CA 1.496 1.849 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.707 0.765 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -52.65 -44.27 66.03 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.193 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -53.48 -55.78 22.48 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.6 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.66 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.05 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.44 -52.67 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -57.46 -48.81 78.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.485 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.74 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -52.29 -55.19 23.02 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.046 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.16 -47.29 65.53 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.374 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -55.27 -50.32 69.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.31 -52.34 59.43 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.406 1.098 . . . . 0.0 109.329 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 20' ' ' PHE . 58.8 t -51.69 -49.3 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.238 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.81 -45.63 5.85 Favored Glycine 0 N--CA 1.501 2.971 0 O-C-N 124.963 1.414 . . . . 0.0 112.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -82.37 -50.64 8.68 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.885 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -50.42 -48.79 56.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -50.1 -35.91 27.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.53 -57.23 20.88 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.6 -44.15 96.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -53.78 -49.67 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.46 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.69 -45.96 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -53.75 37.27 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.715 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.39 -36.82 85.15 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.072 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.5 tpt -60.84 -45.95 92.46 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.65 -54.42 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.13 -1.395 . . . . 0.0 108.535 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.58 -18.96 0.02 OUTLIER Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.915 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.94 -2.31 13.53 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.683 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.4 31.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.771 0.796 . . . . 0.0 108.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 116.371 -1.776 . . . . 0.0 109.952 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -47.11 -45.85 22.46 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.444 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -60.71 2.88 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.069 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -64.15 -36.19 83.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.407 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -53.42 -56.07 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -50.8 -49.8 57.63 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.955 0.883 . . . . 0.0 109.225 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -53.93 -52.33 60.96 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.58 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.49 -45.67 62.9 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.92 -50.78 67.96 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.01 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -51.83 -51.93 52.99 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.042 1.401 . . . . 0.0 109.4 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 20' ' ' PHE . 39.4 t -53.92 -48.78 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.348 -2.206 . . . . 0.0 110.625 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.51 -50.64 18.12 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -46.57 -55.82 7.0 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.203 1.001 . . . . 0.0 109.883 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -62.48 -48.93 77.44 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.513 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -44.59 -47.29 10.33 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.915 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.54 -55.21 14.06 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.51 83.24 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.091 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mt -49.13 -49.9 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.998 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.84 -51.86 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.23 35.95 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.42 -53.68 26.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.2 ptm -60.59 -35.8 76.99 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.782 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.42 -50.47 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.71 40.71 2.12 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.27 -32.67 0.48 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 39' ' ' VAL . 71.7 t 41.83 36.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.499 1.142 . . . . 0.0 111.475 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.338 -1.792 . . . . 0.0 109.793 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.669 0.747 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.38 -45.86 62.61 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.067 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -50.58 -57.3 8.49 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.303 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.63 -38.3 90.52 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.314 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -52.88 -52.22 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.65 -50.88 69.03 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.817 0.818 . . . . 0.0 109.48 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -53.26 -55.19 26.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.941 -1.482 . . . . 0.0 109.856 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.39 64.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.201 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -53.02 62.93 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -47.53 -53.28 14.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.191 0.996 . . . . 0.0 109.595 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 20' ' ' PHE . 93.6 t -55.19 -53.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.86 -49.16 9.16 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -70.25 -65.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.983 -1.108 . . . . 0.0 110.812 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -61.6 -73.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.33 -36.07 13.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.75 -59.37 10.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.48 87.57 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.143 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.54 -56.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.25 -45.6 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -51.55 47.73 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.715 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -39.29 92.83 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 118.459 -1.296 . . . . 0.0 111.135 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.98 80.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.866 0.729 . . . . 0.0 109.406 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.96 -55.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.549 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.15 49.68 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.84 -1.172 . . . . 0.0 111.973 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.69 -35.93 83.68 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.89 48.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.593 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.761 0.315 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -57.49 -43.62 84.29 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.81 0.814 . . . . 0.0 109.051 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 tptm -57.32 -53.19 60.92 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.421 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -62.76 -39.53 94.43 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.346 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.21 -55.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -60.77 -47.12 87.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.562 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.49 -54.01 38.16 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.091 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.44 -44.48 65.5 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.289 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.51 -52.66 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.28 -52.37 53.2 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.568 1.175 . . . . 0.0 109.646 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.9 t -53.4 -48.83 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 112.735 -2.029 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.57 -51.28 7.99 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 t -67.15 -58.71 4.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.839 -1.18 . . . . 0.0 110.66 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.3 -71.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.498 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.15 -34.8 23.52 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.18 -60.12 9.49 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.15 -44.12 87.7 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.7 mt -53.25 -55.9 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.89 -46.53 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.64 -50.38 49.21 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.38 -48.64 80.85 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.832 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.2 tpt -52.87 -49.47 65.76 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.98 0.8 . . . . 0.0 110.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.13 -53.07 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.65 -113.92 1.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 -29.42 5.8 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.44 36.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.594 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -59.72 -12.59 7.39 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 0.0 111.237 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -69.06 -51.12 42.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -59.46 -34.92 73.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.885 -1.962 . . . . 0.0 107.489 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.14 -57.2 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -48.7 -49.66 36.9 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.741 0.781 . . . . 0.0 109.784 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.3 t80 -54.53 -53.44 54.44 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.174 -1.376 . . . . 0.0 108.594 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.05 61.88 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.557 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.0 -51.76 68.34 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.2 -54.0 14.97 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.62 1.2 . . . . 0.0 109.428 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 20' ' ' PHE . 83.7 t -53.95 -53.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.684 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.87 -51.25 18.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -62.59 -60.53 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.575 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -58.53 -70.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.044 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -35.82 30.29 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.49 -59.21 11.27 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.0 mt -51.73 -55.64 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.709 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.75 -47.42 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -50.2 47.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 mt -58.88 -48.97 79.52 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.669 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 mtt -53.97 -50.04 67.42 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.913 0.758 . . . . 0.0 110.307 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.24 -50.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.344 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.43 -55.21 27.99 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.88 -33.67 3.93 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.94 27.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.193 -1.861 . . . . 0.0 107.735 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.711 ' HB1' ' H ' ' A' ' 6' ' ' HIS . . . -84.19 103.51 13.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.28 -19.88 64.98 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 123.954 0.784 . . . . 0.0 108.941 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.6 t80 176.64 103.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 41.61 61.28 1.9 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 121.117 0.484 . . . . 0.0 112.088 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.711 ' H ' ' HB1' ' A' ' 2' ' ' ALA . 28.0 p80 38.85 35.19 0.11 Allowed 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -59.07 154.98 14.59 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.599 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 p -73.06 157.38 37.45 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.957 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.64 84.55 0.05 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -54.14 -25.17 20.87 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.481 0.753 . . . . 0.0 110.609 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 69.64 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 125.224 1.578 . . . . 0.0 111.38 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.583 HG21 ' CB ' ' A' ' 15' ' ' GLN . 23.6 m -139.9 -166.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.117 0.484 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -74.88 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.506 -1.224 . . . . 0.0 111.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.64 -4.22 2.92 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 123.798 0.686 . . . . 0.0 112.091 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' CB ' HG21 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -64.2 -23.69 67.4 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -60.6 -43.06 97.86 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -67.38 -43.68 80.78 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.9 t -52.5 -52.09 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -57.99 -46.59 84.96 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.64 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.04 -51.92 54.34 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.41 -46.77 66.48 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -57.58 -49.55 76.02 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.205 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -49.6 -53.3 24.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.552 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 20' ' ' PHE . 88.3 t -54.12 -53.27 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 113.085 -1.871 . . . . 0.0 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.89 -54.52 17.9 Favored Glycine 0 N--CA 1.496 2.68 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.546 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -64.47 -51.45 63.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.862 -0.669 . . . . 0.0 111.045 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -41.92 -45.46 3.75 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.053 -0.976 . . . . 0.0 113.138 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -36.6 -39.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.463 1.102 . . . . 0.0 112.798 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.37 -58.1 15.0 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.93 83.54 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.104 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -53.64 -54.28 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.153 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.2 mt -54.87 -47.6 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.99 -49.63 54.56 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.0 -48.58 79.6 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.642 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.4 mtp -52.0 -49.67 62.87 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.155 0.909 . . . . 0.0 109.516 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.0 -53.19 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.719 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.11 137.91 4.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.41 97.92 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -96.83 33.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.109 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . . . -95.21 60.54 2.33 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 53.33 37.47 25.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 113.049 -1.887 . . . . 0.0 112.393 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 23.9 m-85 -112.94 26.04 10.86 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.268 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 46.36 1.5 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 p80 38.25 29.04 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.698 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.64 117.3 1.12 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 113.812 -1.54 . . . . 0.0 112.589 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.465 ' H ' ' CG1' ' A' ' 24' ' ' VAL . 21.7 m -158.56 166.91 30.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.912 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.75 69.19 0.02 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -161.06 170.97 19.44 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -86.07 119.96 26.93 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.612 HG13 HG23 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -112.14 172.93 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.438 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 18.5 m-70 -83.67 28.3 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.455 ' H ' HG22 ' A' ' 12' ' ' VAL . 99.0 m-70 -151.09 109.28 3.74 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -14.22 3.08 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.26 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -74.89 -57.14 4.09 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' CB ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -59.59 -37.43 78.51 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.486 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.612 HG23 HG13 ' A' ' 12' ' ' VAL . 11.2 t -53.42 -53.26 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -54.31 -49.46 69.6 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.42 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -55.51 -54.96 37.42 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.98 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.62 -45.6 63.31 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.478 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -56.91 -52.26 65.86 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -50.76 -52.27 42.32 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 123.085 1.421 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 20' ' ' PHE . 48.0 t -54.64 -50.8 56.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 112.382 -2.19 . . . . 0.0 110.982 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.35 -56.49 23.16 Favored Glycine 0 N--CA 1.492 2.373 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.154 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 p -53.41 -47.71 69.35 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.65 -59.59 4.4 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.618 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -50.97 -44.59 60.66 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.065 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.38 -55.0 30.67 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.73 80.52 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.413 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.4 mt -51.31 -54.29 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.351 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.91 -48.45 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.96 58.29 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.79 -47.89 81.25 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.519 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -52.34 -54.49 31.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.771 0.67 . . . . 0.0 109.227 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -52.85 -53.65 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 125.182 1.551 . . . . 0.0 110.294 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -109.53 61.99 0.29 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 40' ' ' VAL . . . -159.17 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -84.67 29.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.098 0.951 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLY . 55.3 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 116.441 -1.742 . . . . 0.0 109.76 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.03 147.52 11.34 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.81 -40.41 95.14 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.027 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.9 t80 60.67 99.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 124.897 1.373 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -135.16 26.74 3.53 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.594 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -87.92 42.81 1.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.668 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.54 80.38 2.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.146 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -143.52 131.39 21.53 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.434 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.64 -57.21 0.48 Allowed Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.03 156.4 37.54 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -135.14 128.36 31.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.31 162.25 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-O 122.594 1.188 . . . . 0.0 113.577 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -115.53 65.6 0.69 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.006 -2.361 . . . . 0.0 106.731 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 53.67 31.52 12.88 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.222 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -48.06 -32.4 6.69 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.435 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -53.18 54.55 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.456 0.646 . . . . 0.0 110.601 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -68.29 -36.44 79.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.207 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG12 ' OE2' ' A' ' 22' ' ' GLU . 89.3 t -53.68 -49.7 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -55.97 -49.51 73.36 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.695 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.27 -55.51 20.85 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.822 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.04 -46.51 68.49 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.646 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' OE2' HG12 ' A' ' 18' ' ' VAL . 25.1 mt-10 -56.61 -49.54 74.64 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -52.91 -53.41 49.67 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.203 1.001 . . . . 0.0 109.207 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 20' ' ' PHE . 63.4 t -49.59 -51.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 113.045 -1.889 . . . . 0.0 109.669 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.15 -54.39 35.94 Favored Glycine 0 N--CA 1.498 2.811 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -50.36 -51.79 42.81 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.708 0.766 . . . . 0.0 110.617 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.13 -62.49 1.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.458 -1.247 . . . . 0.0 113.432 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -55.36 -37.61 67.73 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.168 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.27 -56.67 23.83 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.84 77.41 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.735 0.778 . . . . 0.0 110.821 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.2 mt -53.64 -56.89 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.311 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.9 mt -55.88 -41.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.75 -53.49 39.01 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -38.23 86.65 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtp -60.35 -52.89 63.31 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -54.49 -47.19 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.592 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.09 -27.42 3.59 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.287 0.992 . . . . 0.0 113.112 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.88 32.32 24.24 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.23 23.57 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.773 0.796 . . . . 0.0 109.982 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 116.609 -1.662 . . . . 0.0 109.829 179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.2 34.17 5.01 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.537 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.39 68.08 0.92 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -162.77 92.94 0.8 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.935 -1.484 . . . . 0.0 107.863 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -156.78 27.74 0.32 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -161.09 48.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.516 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.11 139.77 58.74 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.494 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.39 82.05 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.197 0.935 . . . . 0.0 109.117 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.74 -3.73 0.24 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.938 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -56.06 141.5 39.91 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.058 0.456 . . . . 0.0 110.995 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -166.32 -6.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -74.29 -178.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 122.173 0.987 . . . . 0.0 112.068 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -152.52 90.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 112.664 -2.062 . . . . 0.0 105.933 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.435 ' HB3' HD23 ' A' ' 17' ' ' LEU . 6.3 m170 58.04 27.3 14.67 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.248 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.08 -35.66 67.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -52.47 -50.02 63.51 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.268 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -66.67 -41.72 87.71 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.11 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.6 -51.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.91 -48.55 79.57 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.989 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.733 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -50.71 -51.77 46.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.2 -49.31 61.25 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.089 0.471 . . . . 0.0 110.604 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -55.94 -47.96 76.6 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -52.88 -51.83 59.7 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.338 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' PHE . 71.2 t -50.56 -48.99 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.588 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.18 -55.53 27.81 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -52.24 -47.75 65.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.976 0.893 . . . . 0.0 110.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -51.2 -57.55 8.49 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.575 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.28 -46.71 18.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 123.469 0.481 . . . . 0.0 110.176 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.56 -56.04 26.67 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.8 78.87 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.304 0.573 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -51.5 -53.11 17.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 69.3 mt -53.58 -48.17 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.72 -51.33 53.42 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -55.77 -45.18 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.783 -0.208 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 67.0 mtp -55.22 -53.25 58.41 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -49.4 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 124.77 1.294 . . . . 0.0 109.691 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.16 -57.25 13.63 Favored Glycine 0 N--CA 1.494 2.528 0 O-C-N 124.168 0.918 . . . . 0.0 112.8 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.14 -9.36 0.03 OUTLIER Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.22 33.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 116.122 -1.894 . . . . 0.0 111.599 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.01 97.82 3.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.424 0.631 . . . . 0.0 109.363 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 60.35 4.68 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 123.067 1.413 . . . . 0.0 109.093 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -147.51 59.09 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 112.047 -2.342 . . . . 0.0 105.023 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 59.05 38.2 24.1 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.545 -1.662 . . . . 0.0 111.552 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.49 75.61 1.41 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -65.45 -158.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.899 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 t -147.95 67.46 1.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.67 36.81 Favored Glycine 0 N--CA 1.499 2.845 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -74.11 133.56 42.83 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.467 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.43 132.99 37.54 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 m -102.99 164.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 124.28 0.988 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -78.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.116 -1.856 . . . . 0.0 109.267 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.74 20.93 3.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.118 0.887 . . . . 0.0 109.807 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.81 -32.04 63.2 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.524 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -53.57 54.46 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.722 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -66.74 -38.39 86.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.286 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.8 t -52.56 -53.09 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -54.36 -49.48 69.72 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.72 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -51.2 -54.05 29.21 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.702 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.41 67.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -56.68 -48.35 77.82 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.028 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -52.25 -51.36 58.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.134 0.896 . . . . 0.0 110.008 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 20' ' ' PHE . 66.0 t -52.81 -50.45 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-N 112.805 -1.998 . . . . 0.0 110.518 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.08 -54.8 33.67 Favored Glycine 0 N--CA 1.495 2.624 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.494 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.4 t -76.08 -5.46 46.64 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.13 -53.09 62.14 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.109 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -50.58 -40.44 52.44 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.52 -58.58 13.83 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.42 -44.13 75.98 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.502 0.667 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.3 mt -53.1 -55.76 10.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.896 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -55.31 -46.64 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.194 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.14 -49.17 60.54 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.92 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -66.05 -33.83 76.7 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 117.703 -1.599 . . . . 0.0 108.799 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.58 -59.19 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.649 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.54 -76.19 1.12 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.34 -68.53 0.07 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.35 57.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 99.8 t . . . . . 0 N--CA 1.496 1.849 0 CA-C-N 112.476 -2.147 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.916 0.389 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.84 26.47 2.62 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -102.9 48.06 0.87 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -122.77 75.39 1.27 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 112.996 -1.911 . . . . 0.0 107.652 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 52.86 72.77 0.39 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.831 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.6 p-80 34.25 39.35 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.71 -1.586 . . . . 0.0 115.162 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.88 164.25 10.56 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.411 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p 47.35 -160.11 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.806 1.317 . . . . 0.0 113.365 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.27 -65.17 0.09 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.1 t80 62.22 140.21 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.974 1.044 . . . . 0.0 113.126 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.63 113.54 15.57 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.58 174.48 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.213 0.946 . . . . 0.0 109.181 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -73.52 0.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.099 -1.41 . . . . 0.0 107.227 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.407 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -148.56 14.65 0.97 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.245 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' NE2' ' H ' ' A' ' 14' ' ' HIS . 1.8 mp0 -52.65 -44.27 66.03 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.193 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -53.48 -55.78 22.48 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.6 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.66 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.05 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.44 -52.67 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -57.46 -48.81 78.17 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.485 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.74 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -52.29 -55.19 23.02 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.046 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.16 -47.29 65.53 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.374 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -55.27 -50.32 69.8 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.31 -52.34 59.43 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.406 1.098 . . . . 0.0 109.329 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 20' ' ' PHE . 58.8 t -51.69 -49.3 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-N 112.703 -2.044 . . . . 0.0 111.238 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -42.81 -45.63 5.85 Favored Glycine 0 N--CA 1.501 2.971 0 O-C-N 124.963 1.414 . . . . 0.0 112.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -82.37 -50.64 8.68 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.885 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -50.42 -48.79 56.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -50.1 -35.91 27.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.53 -57.23 20.88 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.6 -44.15 96.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -53.78 -49.67 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.46 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -58.69 -45.96 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.7 -53.75 37.27 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.022 -1.085 . . . . 0.0 111.715 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.39 -36.82 85.15 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.628 -1.229 . . . . 0.0 112.072 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.5 tpt -60.84 -45.95 92.46 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.65 -54.42 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.13 -1.395 . . . . 0.0 108.535 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.58 -18.96 0.02 OUTLIER Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.915 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.94 -2.31 13.53 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.683 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.4 31.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.771 0.796 . . . . 0.0 108.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 116.371 -1.776 . . . . 0.0 109.952 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.917 0.389 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.94 135.29 10.26 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.063 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.67 -18.29 61.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 123.778 0.673 . . . . 0.0 110.536 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 57.85 20.84 6.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.309 1.005 . . . . 0.0 110.871 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.04 37.92 1.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.801 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -154.47 18.18 0.47 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 114.546 -1.207 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.36 125.67 42.12 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 113.178 -1.828 . . . . 0.0 109.514 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 t 57.99 42.37 22.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.36 1.038 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.33 -69.47 1.38 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 11' ' ' GLU . 85.4 t80 -168.57 154.34 6.72 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.559 0.695 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 3.7 tm-20 -165.27 144.15 6.46 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.778 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.59 -152.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -120.59 -82.88 0.65 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 17.4 0.99 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.924 0.765 . . . . 0.0 109.821 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -47.11 -45.85 22.46 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.444 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -60.71 2.88 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.069 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -64.15 -36.19 83.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.407 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.9 t -53.42 -56.07 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -50.8 -49.8 57.63 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.955 0.883 . . . . 0.0 109.225 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.716 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -53.93 -52.33 60.96 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.58 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.49 -45.67 62.9 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.92 -50.78 67.96 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.01 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -51.83 -51.93 52.99 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 123.042 1.401 . . . . 0.0 109.4 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 20' ' ' PHE . 39.4 t -53.92 -48.78 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 112.348 -2.206 . . . . 0.0 110.625 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.51 -50.64 18.12 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -46.57 -55.82 7.0 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.203 1.001 . . . . 0.0 109.883 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -62.48 -48.93 77.44 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.513 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -44.59 -47.29 10.33 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.915 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.54 -55.21 14.06 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.51 83.24 Favored 'General case' 0 N--CA 1.503 2.191 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.091 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.5 mt -49.13 -49.9 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.998 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.84 -51.86 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.87 -41.23 35.95 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.42 -53.68 26.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.2 ptm -60.59 -35.8 76.99 Favored 'General case' 0 N--CA 1.505 2.317 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.782 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.42 -50.47 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.71 40.71 2.12 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.27 -32.67 0.48 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 39' ' ' VAL . 71.7 t 41.83 36.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.499 1.142 . . . . 0.0 111.475 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 116.338 -1.792 . . . . 0.0 109.793 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 120.708 0.29 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.6 73.46 5.92 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.273 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -129.88 47.96 2.44 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.262 -1.335 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.35 68.64 3.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.698 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 64.42 82.0 0.19 Allowed 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.883 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -88.85 48.97 1.7 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.637 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.9 174.11 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.924 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.6 t 57.48 37.46 27.77 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.299 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -41.11 94.08 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.34 -33.54 75.97 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.657 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 62.96 107.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 125.004 1.44 . . . . 0.0 111.219 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -78.13 -172.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -73.86 0.21 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 11.52 0.89 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.097 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -51.38 -45.86 62.61 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.067 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -50.58 -57.3 8.49 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.303 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -64.63 -38.3 90.52 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.314 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -52.88 -52.22 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.65 -50.88 69.03 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.817 0.818 . . . . 0.0 109.48 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -53.26 -55.19 26.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 113.941 -1.482 . . . . 0.0 109.856 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.39 64.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.201 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.64 -53.02 62.93 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -47.53 -53.28 14.86 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.191 0.996 . . . . 0.0 109.595 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 20' ' ' PHE . 93.6 t -55.19 -53.14 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.86 -49.16 9.16 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -70.25 -65.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.983 -1.108 . . . . 0.0 110.812 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -61.6 -73.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -48.33 -36.07 13.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.75 -59.37 10.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.48 87.57 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.143 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mt -54.54 -56.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 114.695 -1.138 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.0 mt -55.25 -45.6 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.63 -51.55 47.73 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.715 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -39.29 92.83 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 118.459 -1.296 . . . . 0.0 111.135 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -47.98 80.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.866 0.729 . . . . 0.0 109.406 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.96 -55.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.549 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.15 49.68 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.84 -1.172 . . . . 0.0 111.973 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.69 -35.93 83.68 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.89 48.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 105.439 -2.059 . . . . 0.0 105.439 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.498 1.953 0 CA-C-N 113.23 -1.805 . . . . 0.0 111.593 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.33 75.32 0.8 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.784 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.16 -18.7 55.22 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 23.9 m-85 69.02 30.55 4.43 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 124.334 1.022 . . . . 0.0 112.658 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -98.64 63.81 1.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 4' ' ' PHE . 6.8 m-70 -80.98 33.46 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.39 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.53 134.77 40.67 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.128 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -67.27 143.79 56.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 123.919 0.762 . . . . 0.0 111.09 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.13 -72.81 1.13 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.493 ' CE2' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -157.58 -67.5 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.493 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 2.1 tp10 -168.61 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.738 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.493 HG13 ' CE2' ' A' ' 10' ' ' TYR . 19.6 m -74.45 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.345 0.593 . . . . 0.0 110.324 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -61.23 -89.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.104 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 2.84 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.459 0.474 . . . . 0.0 111.298 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -57.49 -43.62 84.29 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.81 0.814 . . . . 0.0 109.051 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 tptm -57.32 -53.19 60.92 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.421 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -62.76 -39.53 94.43 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.346 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -51.21 -55.65 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -60.77 -47.12 87.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.562 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -52.49 -54.01 38.16 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.091 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.44 -44.48 65.5 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.289 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.51 -52.66 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.28 -52.37 53.2 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.568 1.175 . . . . 0.0 109.646 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 20' ' ' PHE . 38.9 t -53.4 -48.83 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 112.735 -2.029 . . . . 0.0 110.826 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -44.57 -51.28 7.99 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.8 t -67.15 -58.71 4.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 113.839 -1.18 . . . . 0.0 110.66 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -57.3 -71.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.498 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.15 -34.8 23.52 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.18 -60.12 9.49 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.15 -44.12 87.7 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.034 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.7 mt -53.25 -55.9 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.271 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.2 mt -56.89 -46.53 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.64 -50.38 49.21 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.38 -48.64 80.85 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.832 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.2 tpt -52.87 -49.47 65.76 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 123.98 0.8 . . . . 0.0 110.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.13 -53.07 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.648 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.65 -113.92 1.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.62 -29.42 5.8 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.44 36.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.594 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.84 133.17 31.67 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.975 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' H ' ' CB ' ' A' ' 8' ' ' SER . 30.1 tt0 -81.09 -105.77 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -156.85 88.65 1.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.198 0.523 . . . . 0.0 111.807 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 48.66 24.9 0.86 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.888 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.476 ' C ' ' H ' ' A' ' 8' ' ' SER . 13.4 t-160 -113.08 -114.23 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.86 33.32 0.12 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 124.134 0.896 . . . . 0.0 110.81 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 6' ' ' HIS . 57.7 p -162.47 26.16 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.79 -19.85 0.03 OUTLIER Glycine 0 N--CA 1.498 2.82 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.126 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -83.65 -142.0 0.07 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -168.74 -42.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 18' ' ' VAL . 12.4 m -139.19 -165.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.555 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -153.21 5.62 0.35 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 111.067 -2.788 . . . . 0.0 104.443 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -156.31 128.61 7.56 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.636 1.174 . . . . 0.0 108.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -59.72 -12.59 7.39 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 0.0 111.237 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -69.06 -51.12 42.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 38.7 mt -59.46 -34.92 73.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.885 -1.962 . . . . 0.0 107.489 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' N ' HG11 ' A' ' 12' ' ' VAL . 1.0 OUTLIER -59.14 -57.2 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -48.7 -49.66 36.9 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.741 0.781 . . . . 0.0 109.784 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 24' ' ' VAL . 1.3 t80 -54.53 -53.44 54.44 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.174 -1.376 . . . . 0.0 108.594 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.15 -46.05 61.88 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.557 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.0 -51.76 68.34 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -48.2 -54.0 14.97 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.62 1.2 . . . . 0.0 109.428 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 20' ' ' PHE . 83.7 t -53.95 -53.79 25.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.684 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.87 -51.25 18.9 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -62.59 -60.53 3.39 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.575 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -58.53 -70.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.044 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.42 -35.82 30.29 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.49 -59.21 11.27 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.04 -45.18 83.36 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.0 mt -51.73 -55.64 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.709 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.75 -47.42 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.29 -50.2 47.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.4 mt -58.88 -48.97 79.52 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.669 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.3 mtt -53.97 -50.04 67.42 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.913 0.758 . . . . 0.0 110.307 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.24 -50.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.344 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.43 -55.21 27.99 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.88 -33.67 3.93 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.94 27.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.193 -1.861 . . . . 0.0 107.735 -179.886 . . . . . . . . 0 0 . 1 stop_ save_